Initial Combination Therapy with Adalimumab Plus Methotrexate Leads to Better Long-Term Outcomes Than with Either Monotherapy in Patients with Early Rheumatoid Arthritis: 8-Year Results of An Open-Label Extension of a Phase 3 Trial
Author(s):
Breedveld, F.C.; Keystone, E.; Heijde, D. van der; Landewe, R.; Smolen, J.; Guerette, B.; McIlraith, M.; Kupper, H.; Liu, S.F.; Wolfe, B.; Kavanaugh, A.
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-10-31
Language
English
Is part of
Arthritis and Rheumatism (2011), Vol. 63, no. 10, p. S481-S481
